What is KLTO's current stock price?

KLTO (Klotho Neurosciences, Inc.) is currently trading at $0.38 with a market cap of $20.1M.

What sector is Klotho Neurosciences, Inc. in?

Klotho Neurosciences, Inc. (KLTO) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

KLTO Klotho Neurosciences, Inc.

Healthcare

$0.38+0.00%OpenMarket Cap: $20.1M

As of 2026-05-26

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

2.99

P/S

0.00

EV/EBITDA

-2.95

DCF Value

$-0.01

FCF Yield

-20.7%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-137.6%

ROA

-110.0%

ROIC

-75.1%

Financials

View All

Period	Revenue	Net Income	EPS
Q3 null	$0.00	$-2.9M	$—
Q2 null	$0.00	$-4.1M	$—
Q1 null	$0.00	$-2.2M	$—
Q4 null	$0.00	$-2.1M	$—

Trading Activity

Insider Trades

View All

ZENTMAN SAMUEL Mdirector

SellFri Mar 06

SINKULE JOSEPHdirector, officer: Chief Executive Officer

SellFri Mar 06

McGarity Jondirector

SellFri Mar 06

LeBlanc Jeffofficer: Chief Financial Officer

SellFri Mar 06

Hirschman Shalomdirector

SellFri Mar 06

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

2.23

Klotho Neurosciences, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates include AMI-101 for the treatment or prevention of Alzheimer's disease; and AMI-202 to treat and prevent amyotrophic lateral sclerosis. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. The company is based in Omaha, Nebraska.

Peers